JP2013544510A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544510A5
JP2013544510A5 JP2013535585A JP2013535585A JP2013544510A5 JP 2013544510 A5 JP2013544510 A5 JP 2013544510A5 JP 2013535585 A JP2013535585 A JP 2013535585A JP 2013535585 A JP2013535585 A JP 2013535585A JP 2013544510 A5 JP2013544510 A5 JP 2013544510A5
Authority
JP
Japan
Prior art keywords
sequence
rna
nucleotides
length
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013535585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544510A (ja
Filing date
Publication date
Priority claimed from PCT/IL2010/000895 external-priority patent/WO2012056441A1/en
Application filed filed Critical
Publication of JP2013544510A publication Critical patent/JP2013544510A/ja
Publication of JP2013544510A5 publication Critical patent/JP2013544510A5/ja
Pending legal-status Critical Current

Links

JP2013535585A 2010-10-28 2011-10-27 細胞において外来性rnaを特異的に切断するための組成物および方法 Pending JP2013544510A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ILPCT/IL2010/000895 2010-10-28
PCT/IL2010/000895 WO2012056441A1 (en) 2010-10-28 2010-10-28 Compositions and methods for specific cleavage of exogenous rna in a cell
PCT/IL2011/000827 WO2012056449A2 (en) 2010-10-28 2011-10-27 Compositions and methods for specific cleavage of exogenous rna in a cell

Publications (2)

Publication Number Publication Date
JP2013544510A JP2013544510A (ja) 2013-12-19
JP2013544510A5 true JP2013544510A5 (enExample) 2014-12-11

Family

ID=45993240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013535585A Pending JP2013544510A (ja) 2010-10-28 2011-10-27 細胞において外来性rnaを特異的に切断するための組成物および方法

Country Status (7)

Country Link
US (1) US20130225660A1 (enExample)
EP (1) EP2632931A4 (enExample)
JP (1) JP2013544510A (enExample)
CN (1) CN103282372A (enExample)
AU (1) AU2011322106A1 (enExample)
CA (1) CA2815632A1 (enExample)
WO (2) WO2012056441A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE037173T2 (hu) 2006-08-08 2018-08-28 Univ Bonn Rheinische Friedrich Wilhelms 5'-Foszfát-oligonukleotidok szerkezete és alkalmazása
US9738680B2 (en) 2008-05-21 2017-08-22 Rheinische Friedrich-Wilhelms-Universität Bonn 5′ triphosphate oligonucleotide with blunt end and uses thereof
EP2508530A1 (en) 2011-03-28 2012-10-10 Rheinische Friedrich-Wilhelms-Universität Bonn Purification of triphosphorylated oligonucleotides using capture tags
EP2712870A1 (en) 2012-09-27 2014-04-02 Rheinische Friedrich-Wilhelms-Universität Bonn Novel RIG-I ligands and methods for producing them
US11517583B2 (en) * 2016-04-01 2022-12-06 National University Of Singapore Trans-splicing RNA (tsRNA)
DE102017103383A1 (de) * 2017-02-20 2018-08-23 aReNA-Bio GbR (vertretungsberechtigter Gesellschafter: Dr. Heribert Bohlen, 50733 Köln) System und Verfahren zur Zelltyp-spezifischen Translation von RNA-Molekülen in Eukaryoten
WO2022182697A1 (en) * 2021-02-23 2022-09-01 Board Of Regents, The University Of Texas System A novel rna-based approach to cancer treatment

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869248A (en) * 1994-03-07 1999-02-09 Yale University Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
DE69636937T3 (de) * 1995-12-15 2011-01-05 Virxsys Corp. Durch trans-spaltung erhaltene therapeutische molekule
EP1147188B1 (en) * 1999-01-26 2007-05-16 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Internal ribosome entry site (ires), vector containing same and the uses thereof
AU2003302216A1 (en) * 2002-05-08 2004-06-23 Virxsys Corporation Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses
US20030219407A1 (en) * 2002-05-15 2003-11-27 The Regents Of The University Of California RNA silencing in animals as an antiviral defense
WO2004003180A1 (en) * 2002-07-01 2004-01-08 E.I. Du Pont De Nemours And Company Method of controlling gene silencing using site-specific recombination
EP2000160A3 (en) * 2002-10-30 2009-03-11 Gambro Lundia AB Method and apparatuses for determining the efficiency of dialysis
EP2213738B1 (en) * 2002-11-14 2012-10-10 Dharmacon, Inc. siRNA molecules targeting Bcl-2
WO2005112620A2 (en) * 2004-05-18 2005-12-01 Massachusetts Institute Of Technology A cre-lox based method for conditional rna interference
WO2006042112A2 (en) * 2004-10-05 2006-04-20 California Institute Of Technology Aptamer regulated nucleic acids and uses thereof
CA2583306A1 (en) * 2004-10-08 2006-08-10 Intronn, Inc. Use of rna trans-splicing for antibody gene transfer and antibody polypeptide production
CA2603730A1 (en) * 2005-03-31 2006-10-05 Calando Pharmaceuticals, Inc. Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
CN101184840A (zh) * 2005-03-31 2008-05-21 卡兰朵医药公司 核糖核苷酸还原酶亚基2的抑制剂及其用途
US20090217397A1 (en) * 2006-06-12 2009-08-27 Patrick Stern Cre-lox based gene knockdown constructs and methods of use thereof
US8158595B2 (en) * 2006-11-09 2012-04-17 California Institute Of Technology Modular aptamer-regulated ribozymes
WO2008106658A2 (en) * 2007-03-01 2008-09-04 California Institute Of Technology TRIGGERED RNAi
US8367815B2 (en) * 2007-08-28 2013-02-05 California Institute Of Technology Modular polynucleotides for ligand-controlled regulatory systems
US9029524B2 (en) * 2007-12-10 2015-05-12 California Institute Of Technology Signal activated RNA interference

Similar Documents

Publication Publication Date Title
Liu et al. Circular RNAs: Characterization, cellular roles, and applications
JP2013544510A5 (enExample)
JP2013544511A5 (enExample)
JP2021121205A5 (enExample)
JP7649748B2 (ja) Crispr-casエフェクターポリペプチド及びその使用方法
WO2007091269A3 (en) NOVEL TANDEM siRNAS
JP2014527401A5 (enExample)
EP2495248A4 (en) BRIDGED ARTIFICIAL NUCLEOSIDE AND NUCLEOTIDE
WO2004007718A3 (en) Rna-interference by single-stranded rna molecules
Goto et al. A simple and rapid method to detect plant siRNAs using nonradioactive probes
TW201106977A (en) Development of universal cancer drugs and vaccines
CA2785727A1 (en) Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
WO2008039937A3 (en) Blocking of gene expression in eukaryotic cells
JP6137484B2 (ja) 遺伝子発現抑制用二本鎖核酸分子
ES2651911T3 (es) Métodos mejorados de silenciamiento génico
JP2006523103A5 (enExample)
JP6286050B2 (ja) トリインフルエンザウイルスのmiRNAとその同定、検出および使用
WO2011065677A3 (ko) 암 치료용 약학 조성물
Dunn-Davies et al. Systematic mapping of small nucleolar RNA targets in human cells
WO2009008645A3 (en) Linear double-stranded rna molecule interfering with different target genes
JP2025530174A (ja) 自己環状化rna構造体
CN112226435B (zh) 一组降低尿酸酶基因表达的核苷酸序列及应用
CN104195153B (zh) 一种双顺反子共表达基因转移体及制备方法
WO2006076251A3 (en) Efficient gene suppression using a transfer rna promoter in herpes virus vectors to deliver small interference rnas
US12365900B2 (en) miRNA switches for RNA-triggered control of RNA interference